Senzime AB (publ) develops and markets systems to follow patients' nervous systems and electrical impulses before, during and after surgery. The company's solution, TetraGraph, aims to improve clinical precision and simplify management in healthcare. Through the new share issue, the company raised SEK 73.5 million (before costs related to the issue). Lindahl's team was led by Mattias Prage (responsible partner) with the assistance of Disa Almqvist.
Lindahl advisor to Senzime in connection with a new issue of SEK 73.5 million
Contact
